Neurogene Inc.
NGNE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001404644
In the last 90 days, Neurogene Inc. insiders filed 0 open-market purchases and 2 sales; 111 institutions reported holding it in 13F filings for Q2 2026, worth $544.4M in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Neurogene Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 36
- −3 vs. Q1 2023
- Shares held
- 17.3M
- +2.23M (+14.8%) vs. Q1 2023
- Total value
- $14.3M
- +$3.80M (+36.1%) vs. Q1 2023
- New holders
- 5
- 7 more added
- Sold out
- 8
- 9 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NGNE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 111 | $544.4M |
| Q1 2026 | 96 | $342.0M |
| Q4 2025 | 93 | $340.4M |
| Q3 2025 | 88 | $265.2M |
| Q2 2025 | 83 | $230.1M |
| Q1 2025 | 86 | $192.8M |
| Q4 2024 | 89 | $367.8M |
| Q3 2024 | 86 | $581.1M |
| Q2 2024 | 66 | $482.7M |
| Q1 2024 | 60 | $617.3M |
| Q4 2023 | 35 | $179.0M |
| Q3 2023 | 31 | $14.4M |
| Q2 2023 | 36 | $14.3M |
| Q1 2023 | 39 | $10.5M |
| Q4 2022 | 46 | $8.66M |
| Q3 2022 | 52 | $12.0M |
| Q2 2022 | 64 | $21.4M |
| Q1 2022 | 81 | $46.3M |
| Q4 2021 | 80 | $118.8M |
| Q3 2021 | 85 | $187.1M |
| Q2 2021 | 82 | $248.8M |
| Q1 2021 | 82 | $341.9M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Neurogene Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Baker Bros. Advisors LP | 3,821,740 | $3.17M | 0.02% | 00.0% | Unchanged |
| Lynx1 Capital Management LP | 3,094,554 | $2.57M | 1.68% | +666,231+27.4% | Added |
| Redmile Group, LLC | 2,912,228 | $2.42M | 0.09% | +1,064,628+57.6% | Added |
| Bank of America Corp | 1,160,016 | $962.8K | 0.00% | +3,171+0.3% | Added |
| Vanguard Group Inc | 1,010,812 | $839.0K | 0.00% | −5,484−0.5% | Reduced |
| Renaissance Technologies LLC | 937,223 | $778.0K | 0.00% | +22,610+2.5% | Added |
| Western Standard LLC | 860,882 | $714.5K | 0.62% | +860,882 | New |
| Morgan Stanley | 821,972 | $682.2K | 0.00% | +3070.0% | Added |
| Millennium Management LLC | 609,651 | $506.0K | 0.00% | −167,497−21.6% | Reduced |
| BlackRock Inc. | 483,948 | $401.7K | 0.00% | −80,527−14.3% | Reduced |
| Geode Capital Management, LLC | 301,057 | $249.9K | 0.00% | 00.0% | Unchanged |
| Two Sigma Investments, LP | 211,194 | $175.3K | 0.00% | −15,500−6.8% | Reduced |
| Two Sigma Advisers, LP | 184,500 | $153.1K | 0.00% | −49,700−21.2% | Reduced |
| Point72 Asset Management, L.P. | 136,675 | $113.4K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 122,556 | $101.7K | 0.00% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 119,966 | $99.6K | 0.02% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 117,200 | $94.9K | 0.07% | 00.0% | Unchanged |
| Alta Fundamental Advisers LLC | 89,702 | $74.5K | 0.04% | +89,702 | New |
| Northern Trust Corp | 69,541 | $57.7K | 0.00% | −224−0.3% | Reduced |
| HighTower Advisors, LLC | 48,409 | $40.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 47,891 | $39.8K | 0.00% | +47,891 | New |
| US Bancorp | 44,346 | $36.8K | 0.00% | 00.0% | Unchanged |
| BML Capital Management, LLC | 23,749 | $19.7K | 0.02% | 00.0% | Unchanged |
| Simon Quick Advisors, LLC | 23,428 | $19.4K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 14,372 | $11.9K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 8,244 | $6.84K | 0.00% | +11+0.1% | Added |
| Federated Hermes, Inc. | 1,555 | $1.29K | 0.00% | −348−18.3% | Reduced |
| Group One Trading, L.P. | 1,504 | $1.25K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 1,500 | $1.25K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,100 | $913 | 0.00% | −13,805−92.6% | Reduced |
| Farther Finance Advisors, LLC | 1,000 | $830 | 0.00% | +1,000 | New |
| Truvestments Capital LLC | 925 | $768 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 223 | $185 | 0.00% | 00.0% | Unchanged |
| National Bank of Canada | 175 | $144 | 0.00% | +175 | New |
| Barclays PLC | 163 | $135 | 0.00% | −5,127−96.9% | Reduced |
| Royal Bank of Canada | 592 | $0 | 0.00% | +389+191.6% | Added |
| Bridgeway Capital Management, LLC | 0 | $0 | 0.00% | −75,000−100.0% | Sold out |
| MYDA Advisors LLC | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Endurance Wealth Management, Inc. | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −16,991−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −13,441−100.0% | Sold out |
| PenderFund Capital Management Ltd. | 0 | $0 | 0.00% | −6,709−100.0% | Sold out |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −622−100.0% | Sold out |